![COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options - Eijk - 2021 - The Journal of Pathology - Wiley Online Library COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options - Eijk - 2021 - The Journal of Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/31554f9c-a587-4e49-9666-3f663efcd1de/path.v254.4.cover.jpg)
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options - Eijk - 2021 - The Journal of Pathology - Wiley Online Library
![A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group - José A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, Romina Nieto, Rosa M Serrano Morales, Guillermina A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group - José A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, Romina Nieto, Rosa M Serrano Morales, Guillermina](https://journals.sagepub.com/cms/10.1177/0961203320988586/asset/images/large/10.1177_0961203320988586-fig1.jpeg)
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group - José A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, Romina Nieto, Rosa M Serrano Morales, Guillermina
![A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group - José A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, Romina Nieto, Rosa M Serrano Morales, Guillermina A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group - José A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, Romina Nieto, Rosa M Serrano Morales, Guillermina](https://journals.sagepub.com/cms/10.1177/0961203320988586/asset/images/large/10.1177_0961203320988586-fig2.jpeg)
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group - José A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, Romina Nieto, Rosa M Serrano Morales, Guillermina
![Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G](https://pubs.rsc.org/image/article/2019/MD/c9md00298g/c9md00298g-s3_hi-res.gif)
Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G
![Los dispositivos de encapsulación celular con tecnología 3D, nueva vía para el tratamiento de la diabetes mellitus tipo 1 - UPV/EHU Los dispositivos de encapsulación celular con tecnología 3D, nueva vía para el tratamiento de la diabetes mellitus tipo 1 - UPV/EHU](https://www.ehu.eus/documents/10136/12435146/web_Figura.jpg/ca8f6eb4-1ee2-99f9-1313-840977d122a9?t=1562932392000)
Los dispositivos de encapsulación celular con tecnología 3D, nueva vía para el tratamiento de la diabetes mellitus tipo 1 - UPV/EHU
![Lucía FARGNOLI | PostDoc Position | PosDoctoral Researcher | ICiVet (LEcEn laboratorio de Ecología de Enfermedades) Lucía FARGNOLI | PostDoc Position | PosDoctoral Researcher | ICiVet (LEcEn laboratorio de Ecología de Enfermedades)](https://www.researchgate.net/profile/Guillermo-Labadie/publication/321468950/figure/fig1/AS:568594309107712@1512574855999/Antimalarial-activity-D6-Clone-by-substituent-The-average-value-of-each-subset-is_Q320.jpg)
Lucía FARGNOLI | PostDoc Position | PosDoctoral Researcher | ICiVet (LEcEn laboratorio de Ecología de Enfermedades)
![Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G](https://pubs.rsc.org/image/article/2019/MD/c9md00298g/c9md00298g-f2_hi-res.gif)
Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G
![Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G](https://pubs.rsc.org/image/article/2019/MD/c9md00298g/c9md00298g-f3_hi-res.gif)
Repositioning Salirasib as a new antimalarial agent - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00298G
Viroinmunoterapia para el tumor rabdoide/teratoide atípico (AT/RT): caracterización del efecto antitumoral del adenovirus Delt
![Pharmaceuticals | Free Full-Text | Lung Cancer Management with Silibinin: A Historical and Translational Perspective | HTML Pharmaceuticals | Free Full-Text | Lung Cancer Management with Silibinin: A Historical and Translational Perspective | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00559/article_deploy/html/images/pharmaceuticals-14-00559-ag.png)